4,005
Participants
Start Date
May 1, 2016
Primary Completion Date
September 1, 2018
Study Completion Date
March 20, 2019
PIVKA-II
Serum samples are tested for tumor markers including PIVKA-II,AFP,AFP-L3% and biochemical tests.
Eastern hepatobiliary surgery hospital, Shanghai
Abbott Diagnostics Division
INDUSTRY
Peking University First Hospital
OTHER
The First Hospital of Jilin University
OTHER
RenJi Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Gansu Provincial Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Sun Yat-sen University
OTHER
Sichuan Provincial People's Hospital
OTHER
Eastern Hepatobiliary Surgery Hospital
OTHER